What Is Process Hazard Analysis? A Guide for Life Sciences and Manufacturing
TLDR: Process Hazard Analysis (PHA) is a structured, systematic methodology used to identify, evaluate, and control hazards in processes that involve hazardous chemicals or complex operational sequences. Mandated by OSHA's Process Safety Management standard, the EPA Risk Management Program, and referenced across FDA and ICH Q9 quality frameworks, PHA is a compliance cornerstone for pharmaceutical manufacturers, medical device companies, chemical processors, and food producers. This guide covers the definition, regulatory context, major PHA methods, life sciences applications, step-by-step execution, QMS integration, and the documentation gaps that most teams overlook.
What Is Process Hazard Analysis?
Process Hazard Analysis, commonly abbreviated as PHA, is an organized effort to identify and evaluate hazards associated with chemical processes or operations. A PHA examines what can go wrong in a process, how likely it is, and what the consequences might be, then identifies safeguards that prevent or mitigate those outcomes.
PHA applies wherever hazardous materials or energies are present: pharmaceutical API synthesis, sterile fill-finish operations, chemical batch reactors, food processing lines, medical device assembly, and more. The goal is proactive risk identification rather than reactive incident response.
The term "process hazard analysis" is sometimes used interchangeably with "process safety analysis" or "process risk assessment," but the PHA designation specifically refers to the structured, documented methodologies recognized under regulatory standards.
The Regulatory Context: Why PHA Is Mandated
Several major regulatory frameworks require or strongly reference PHA, each with distinct applicability.
OSHA Process Safety Management (29 CFR 1910.119)
The Occupational Safety and Health Administration's Process Safety Management of Highly Hazardous Chemicals standard, codified at 29 CFR 1910.119, makes PHA a mandatory element of any PSM program. OSHA PSM applies to facilities that handle threshold quantities of listed highly hazardous chemicals, including many solvents, reactive intermediates, and gases common in pharmaceutical and chemical manufacturing.
Under 29 CFR 1910.119(e), employers must perform an initial PHA on all covered processes and revalidate each PHA at least every five years. The standard specifies that the team must include at least one employee with process engineering expertise and one with operations experience. PHA findings must be documented, action items assigned, and resolution tracked.
EPA Risk Management Program (40 CFR Part 68)
The EPA's Risk Management Program, established under the Clean Air Act Amendments of 1990, requires facilities that handle regulated substances above threshold quantities to develop and implement a Risk Management Plan. Program 3 processes under EPA RMP must conduct a PHA equivalent to OSHA's PSM requirements.
As EPA notes, compliance with OSHA PSM does not automatically satisfy all EPA RMP requirements, and vice versa. The RMP adds an off-site consequence analysis component, focusing on community and environmental protection rather than just worker safety.
FDA HACCP and Food Safety
The Food and Drug Administration's Hazard Analysis and Critical Control Points framework, referenced in 21 CFR Part 123 (seafood) and Part 120 (juice) and more broadly through FDA Food Safety Modernization Act (FSMA) preventive controls requirements, applies PHA principles to food safety. FDA's HACCP guidance frames hazard analysis as the foundation of every food safety plan.
In food manufacturing and beverage production, a hazard analysis evaluates biological, chemical, and physical hazards at each process step to determine where critical control points are needed.
ICH Q9: Quality Risk Management in Pharmaceuticals
The International Council for Harmonisation's Q9(R1) guideline on Quality Risk Management, adopted by the FDA and published in May 2023, provides the overarching framework for risk management across the pharmaceutical product lifecycle. ICH Q9(R1) explicitly identifies HAZOP and FMEA as recognized risk assessment tools for pharmaceutical applications.
ICH Q9 establishes that risk management must be proportionate to the level of risk, documented, and integrated into quality systems, not treated as a one-time compliance exercise.
ISO 14971 for Medical Devices
For medical device manufacturers, ISO 14971:2019 specifies requirements for a risk management process that applies PHA principles throughout the entire device lifecycle. ISO 14971 requires manufacturers to systematically identify all reasonably foreseeable hazards associated with a device, estimate and evaluate the associated risks, and implement controls where risks are not acceptable.
The standard mandates a Risk Management File that documents each identified hazard, its estimated probability and severity, the risk control measures applied, and residual risk acceptability. ISO 14971 is harmonized with both FDA's Quality Management System Regulation (21 CFR Part 820) and ISO 13485, making it the risk analysis backbone for medical device QMS programs worldwide.
Types of Process Hazard Analysis Methods
OSHA's PSM standard explicitly lists several acceptable PHA methodologies. The choice of method depends on process complexity, available data, team expertise, and the stage of process development.
Hazard and Operability Study (HAZOP)
HAZOP is the most widely used PHA method in the chemical, pharmaceutical, and process industries. It applies standardized guide words, such as "No," "More," "Less," "Reverse," and "Other Than," to process parameters like flow, temperature, pressure, and composition. The team systematically asks what happens if each parameter deviates from its design intent.
A HAZOP study is highly thorough and well-suited for complex, continuous, or semi-continuous processes such as Active Pharmaceutical Ingredient synthesis, solvent recovery, and bioreactor operations. It requires detailed Process and Instrumentation Diagrams (P&IDs) and a multidisciplinary team, which makes it resource-intensive but extremely comprehensive.
What-If Analysis
What-If analysis poses open-ended questions about potential process deviations or failures: "What if the agitator fails?" or "What if the wrong solvent is charged?" Teams brainstorm scenarios and evaluate their likelihood and consequences.
What-If is faster and more flexible than HAZOP. It works well for simpler processes, batch operations, or early design stages where detailed P&IDs may not yet exist. It is often combined with checklist methods to improve thoroughness.
Failure Modes and Effects Analysis (FMEA)
FMEA examines how individual components or process steps can fail, the effects of those failures, and their detectability. Each failure mode receives a Risk Priority Number (RPN) calculated by multiplying severity, occurrence, and detection scores.
FMEA is component- and equipment-focused, making it the preferred method for medical device design risk assessment under ISO 14971 and for pharmaceutical equipment qualification. It produces a structured, quantitative output that integrates well with a QMS risk register.
Fault Tree Analysis (FTA)
FTA starts with a defined undesirable top event, such as a toxic release or batch contamination, and works backward using Boolean logic to identify the combinations of equipment failures and human errors that could cause it. The resulting "fault tree" diagram maps cause-and-effect relationships graphically.
FTA is particularly useful when a specific high-consequence scenario needs deep analysis, or when quantitative probability estimates are required to demonstrate that risk has been reduced to an acceptable level.
Checklist Analysis
Checklist analysis uses a predefined list of questions based on established standards, codes of practice, and prior experience to verify that known hazards have been addressed. It is the fastest of the PHA methods but is limited to previously identified hazard types.
Checklist analysis is often used for routine equipment inspections, management of change reviews for minor modifications, and to supplement more rigorous PHA methods during revalidations.
PHA in Life Sciences: Special Considerations
Life sciences manufacturers face a dual compliance challenge: they must satisfy process safety regulations from OSHA and EPA alongside quality and regulatory requirements from the FDA, ISO, and ICH. This means PHA work must be designed to serve both purposes.
Pharmaceutical API Manufacturing
In pharmaceutical manufacturing, Active Pharmaceutical Ingredient production often involves flammable solvents, reactive intermediates, and highly potent compounds. Facilities above OSHA's threshold quantities must conduct a full PSM-compliant PHA. Additionally, FDA expects the risk management process described in ICH Q9 to be applied throughout the product lifecycle, including process design, scale-up, and post-approval changes.
HAZOP is the dominant method for API manufacturing PHA, given the continuous or semi-continuous nature of many synthesis routes. The PHA output connects directly to process validation protocols, engineering controls specifications, and the facility's QMS risk register.
Medical Device Manufacturing and ISO 14971
Medical device manufacturers apply PHA principles at the product design level and the manufacturing process level. At the design stage, FMEA and Hazard Analysis documents as required by ISO 14971 identify risks to patients, operators, and the environment from device use and reasonably foreseeable misuse.
At the manufacturing process level, risk assessments evaluate contamination risks, process capability, and equipment-related failure modes that could compromise device safety or performance. The risk register for a medical device company typically spans product design, process validation, supplier qualification, and post-market surveillance.
Food and Beverage: HACCP as PHA
For food and beverage manufacturers, HACCP functions as the industry-specific PHA framework. Every food safety plan mandated under FDA FSMA preventive controls must begin with a documented hazard analysis that systematically evaluates biological, chemical (including allergens and pesticides), radiological, and physical hazards at each process step.
The hazard analysis determines which hazards require a preventive control, whether a process control, allergen control, sanitation control, or supply chain control. This output drives the entire food safety management system, exactly as a traditional PHA output drives a process safety program.
How to Conduct a Process Hazard Analysis: Step by Step
Regardless of the method chosen, an effective PHA follows a consistent process.
Step 1: Define the Scope and Process Boundaries
Start by specifying which process or process section the PHA covers. Define the boundaries clearly: where the process begins and ends, what feedstocks and products are involved, and what operating modes are included (startup, normal operation, shutdown, emergency). Gather all relevant process documentation, including P&IDs, process flow diagrams, material safety data sheets, and operating procedures.
Step 2: Assemble the Right Team
A credible PHA requires multidisciplinary expertise. The core team typically includes a process engineer, an operations or production representative, a safety or EHS professional, and a facilitator trained in the chosen PHA method. For pharmaceutical applications, quality assurance participation is essential, since PHA findings feed directly into the QMS.
Under OSHA PSM requirements, at least one team member must have experience in the specific process being analyzed, and at least one must be knowledgeable in the PHA method being used.
Step 3: Identify Hazard Scenarios
Using the chosen method, the team systematically identifies hazard scenarios. For HAZOP, this means applying guide words to each parameter at each node. For FMEA, it means enumerating failure modes for each component. For What-If, it means generating and recording "what if" questions and working through their consequences.
Each scenario must be recorded with a description of the deviation or failure, its potential cause, its likely consequence, and the existing safeguards already in place.
Step 4: Evaluate Risk and Existing Safeguards
For each hazard scenario, the team estimates the likelihood of occurrence and the severity of the consequence, taking existing safeguards into account. Many organizations use a risk matrix to assign a risk level.
The team then determines whether the existing safeguards are adequate or whether additional risk reduction measures are needed.
Step 5: Generate and Assign Recommendations
Where existing safeguards are inadequate, the team generates specific recommendations: engineering changes, administrative controls, procedural updates, or additional safeguards. Each recommendation is assigned to an owner with a target completion date.
These recommendations become action items that must be tracked to resolution. This is where PHA connects directly to audits, corrective actions, and change management within the QMS.
Step 6: Document the PHA Report
The completed PHA must be thoroughly documented. The PHA report should include the methodology used, the team roster, the date of the study, all worksheets capturing each hazard scenario evaluated, the risk ranking for each scenario, existing safeguards, and all recommendations with their disposition status.
OSHA requires this documentation to be retained and available to employees. The PHA report also serves as the baseline for future revalidations.
Step 7: Resolve Action Items and Revalidate
PHA is not a one-time activity. Action items must be tracked through completion. OSHA PSM requires that PHA recommendations be resolved promptly and that findings be communicated to affected workers.
Revalidation is required every five years under OSHA PSM. Revalidations may update the original PHA or perform a new study, and must address any changes made to the process since the prior PHA.
How PHA Outputs Feed Into Your QMS
The value of a PHA multiplies significantly when its outputs are fully integrated into the quality management system. Many organizations conduct PHA studies and then file the report, missing the opportunity to connect hazard data to the QMS processes that drive continuous improvement.
Risk Register
PHA-identified hazard scenarios with residual risk should be entered into the risk register. The risk register serves as the central inventory of known risks, their controls, and their current status. When a PHA identifies a high-severity scenario that cannot be fully engineered away, the residual risk needs to live in the risk register where it can be monitored, reviewed at management review cycles, and updated when process changes occur.
Cloudtheapp's Risk Assessments app and Enterprise Risk Management module provide a structured environment to capture, score, and track PHA-derived risks alongside product design risks, supplier risks, and operational risks in a unified register.
CAPA
When a PHA recommendation requires a process modification or a procedural change that addresses an identified hazard, that action is often appropriately managed through a Corrective and Preventive Action workflow. CAPA provides the traceability between the identified hazard, the root cause investigation or risk rationale, the implemented control, and the effectiveness check that confirms the control is working.
Cloudtheapp's Corrective and Preventive Actions app connects directly to risk assessments, enabling teams to link a CAPA directly to the PHA finding that triggered it, creating a full audit trail for regulatory inspections.
Change Management
Process changes, whether driven by equipment modifications, raw material changes, scale-up, or process improvements, require a PHA review before implementation. This is the "Management of Change" element of OSHA PSM, which mandates that any change to process chemicals, technology, equipment, or procedures be evaluated for safety implications before the change goes live.
Cloudtheapp's Change Management app integrates with risk assessment workflows so that every change request automatically triggers a hazard review step, ensuring no process modification bypasses safety evaluation.
Hazard Analysis and HACCP Documentation
For food and beverage manufacturers and pharmaceutical companies operating under FSMA or FDA's cGMP requirements, Cloudtheapp's Hazard Analysis and HACCP applications provide purpose-built documentation tools for capturing hazard analysis worksheets, critical control points, control measure justifications, and corrective action procedures in a fully validated, 21 CFR Part 11-compliant environment.
Common PHA Documentation Gaps
Even well-run PHA programs frequently have documentation gaps that create compliance risk.
Incomplete safeguard documentation. Teams identify hazards but fail to fully document the existing safeguards that justify their risk ranking. During an audit, inspectors expect to see specific safeguard descriptions, not just a risk score.
Unresolved recommendations. PHA action items get generated but never formally closed with evidence of implementation. OSHA requires tracking PHA recommendations to resolution with documentation that the hazard was addressed.
No linkage to Management of Change. Organizations perform an initial PHA but then allow incremental process changes to accumulate without triggering PHA updates. Over time, the original PHA no longer reflects the actual process, undermining its value as a safety and compliance tool.
Inaccessible or paper-based records. PHA documentation stored in file cabinets or uncontrolled spreadsheets makes it difficult to retrieve during regulatory inspections, integrate with QMS processes, or revalidate efficiently.
Missing revalidation documentation. Many facilities perform revalidations verbally or through informal meetings without creating a documented record that demonstrates each original hazard scenario was revisited and updated as needed.
Team composition not documented. OSHA and auditors expect to see evidence that the PHA team included the required expertise. The names, roles, and qualifications of PHA team members must be documented in the PHA report.
Integrating PHA Into a Modern QMS with Cloudtheapp
A structured PHA program becomes significantly more effective when it operates within a connected quality management system. Cloudtheapp's AI-powered, no-code QMS platform provides the tools life sciences and manufacturing organizations need to run PHA as a living, integrated process rather than a static compliance document.
The Hazard Analysis app provides structured worksheets for recording and scoring hazard scenarios. The HACCP app supports food safety hazard analysis and critical control point documentation. The Risk Assessments and Enterprise Risk Management modules maintain a live risk register that connects PHA outputs to ongoing risk monitoring. The Corrective and Preventive Actions and Change Management apps ensure that PHA recommendations are tracked, implemented, and verified, with full traceability for FDA inspections, ISO audits, and OSHA PSM reviews.
Because Cloudtheapp is validated to FDA 21 CFR Part 11 and compliant with ISO 13485, ISO 9001, and ISO 22001, all PHA documentation created in the platform carries the audit trail, electronic signature controls, and controlled document status that regulated industries require.
Ready to see how Cloudtheapp connects process hazard analysis to your entire quality system? Request a Demo at cloudtheapp.com to see the platform in action.
Conclusion
Process hazard analysis is one of the most consequential tools in the safety and quality professional's toolkit. It converts potential catastrophes into documented, managed risks. For life sciences and manufacturing companies, PHA sits at the intersection of OSHA process safety compliance, EPA environmental protection, FDA quality system requirements, and ISO risk management standards. Organizations that treat PHA as a living program, one that feeds directly into their QMS risk register, CAPA system, and change management workflow, are better protected, better prepared for regulatory scrutiny, and better positioned to prevent incidents before they occur.
The challenge is not knowing that PHA matters. The challenge is building the systems and documentation discipline to do it consistently, traceably, and at scale.
Sources: